Preferred Pharmaceuticals, Inc. recalls Duloxetine Delayed-Release Cap USP 30mg
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit
- Products
-
- Duloxetine Delayed-Release Cap USP 30mg
- Where it was sold
-
Product distributed to CA, FL, OK, KS and CT
States: California, Connecticut, Florida, Kansas, Oklahoma
- Units affected
- 66 bottles of 30 tablets
- About this recall
- Duloxetine Delayed-Release Cap USP 30mg, 30-count bottle, Rx only, Preferred Pharmaceutcals, Inc., NDC 68788-9301-03